Used in pharmaceutical research as a potent and selective agonist for serotonin 5-HT2C receptors. Shows potential in the development of treatments for central nervous system disorders, including obesity, depression, and schizophrenia. Its structure allows for high blood-brain barrier penetration, making it suitable for targeting brain receptors. Also employed in studies evaluating receptor subtype selectivity and behavioral pharmacology in animal models.